Brigitta C Brott MD
Interventional Cardiology
Professor of Medicine and Biomedical Engineering
Join to view full profile
1717 6th Ave SBirmingham, AL 35233
Phone+1 800-822-8816
Dr. Brott is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Professor of Medicine and Biomedical Engineering;
Co-Founder & Chief Medical Officer, Endomimetics, LLC;
Baker-Dean Endowed Professor in Interventional Cardiology
Education & Training
Duke University HospitalFellowship, Cardiovascular Disease, 1991 - 1995
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1988 - 1991
Loyola University Chicago Stritch School of MedicineClass of 1988
Massachusetts Institute of TechnologyBS, 1980 - 1984
Certifications & Licensure
AL State Medical License 2000 - 2026
IL State Medical License 2000 - 2002
TN State Medical License 1995 - 2002
American Board of Internal Medicine Cardiovascular Disease- American Board of Internal Medicine Interventional Cardiology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Powerchart and Cerner Healthe, Cerner Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2012, 2014
- CMS Meaningful Use Stage 1 Certification MyHealth@UABMedicine, UAB Health System, 2012, 2014
Publications & Presentations
PubMed
- 2 citationsStructurally constrained and pathology-aware convolutional transformer generative adversarial network for virtual histology staining of human coronary optical coherenc...Xueshen Li, Hongshan Liu, Xiaoyu Song, Charles C Marboe, Brigitta C Brott
Journal of Biomedical Optics. 2024-03-01 - 2 citationsAtherosclerotic three-layer nanomatrix vascular sheets for high-throughput therapeutic evaluation.Jun Chen, Xixi Zhang, Robbie Cross Jr, Yujin Ahn, Gillian Huskin
Biomaterials. 2024-03-01 - Clinical characteristics and outcomes of patients requiring prolonged mechanical circulatory support after high-risk percutaneous coronary intervention.Sugi Min, Mir Babar Basir, Alejandro Lemor, Zhipeng Zhou, Arsalan Abu-Much
Eurointervention. 2024-01-15
Authored Content
- Drug-Eluting Balloon Therapy for in-Stent Restenosis of Drug-Eluting Stents Choose and Prepare the Appropriate LesionMay 2018
Press Mentions
A Novel Therapy Ameliorates Obesity and Type 2 Diabetes in Mice Fed a High-Fat DietApril 29th, 2022- Massive Pulmonary Embolism in a COVID-19 Patient: A Case ReportJuly 21st, 2020
Drug-Eluting Balloons Come up Short for in-Stent RestenosisMay 21st, 2018
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
